Status:
COMPLETED
Assessment of Desogestrel in Ondine Syndrome
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Ondine Syndrome
Eligibility:
FEMALE
10-60 years
Phase:
PHASE2
PHASE3
Brief Summary
The congenital central hypoventilation syndrome (CCHS), also known as the Ondine syndrome, is a very rare genetic disorder. In contrast with healthy people, patients do not increase breathing in respo...
Detailed Description
Rationale of the study The congenital central hypoventilation syndrome (CCHS), also called Ondine syndrome or Ondine's curse, is a rare orphan disease associated with mutations of the PHOX 2B gene. It...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- Ondine syndrome
- Pubescent female
- Exclusion criteria :
- Contra-indications to a treatment with desogestrel.
- Other treatment with estrogens or progestin that cannot be stopped.
Exclusion
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01243697
Start Date
April 1 2011
End Date
September 1 2013
Last Update
November 14 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pitie salpetriere hospital
Paris, France, 75013